RJA
ZGNX

Raymond James & Associates’s Zogenix, Inc. ZGNX Stock Holding History

Raymond James & Associates’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,259
Closed -$303K – 3736
2020
Q1 		$303K Sell
12,259
-284
-2% -$10.3K ﹤0.01% 2766
2019
Q4 		$654K Sell
12,543
-312
-2% -$14.3K ﹤0.01% 2542
2019
Q3 		$515K Buy
12,855
+1,070
+9% +$49.3K ﹤0.01% 2626
2019
Q2 		$563K Sell
11,785
-878
-7% -$35.4K ﹤0.01% 2576
2019
Q1 		$697K Buy
12,663
+1,668
+15% +$79.4K ﹤0.01% 2429
2018
Q4 		$401K Sell
10,995
-3,502
-24% -$143K ﹤0.01% 2690
2018
Q3 		$719K Buy
14,497
+2,911
+25% +$148K ﹤0.01% 2453
2018
Q2 		$512K Buy
11,586
+64
+0.6% +$2.64K ﹤0.01% 2668
2018
Q1 		$461K Buy
11,522
+38
+0.3% +$1.51K ﹤0.01% 2613
2017
Q4 		$460K Buy
+11,484
New +$441K ﹤0.01% 2584

Other funds holding ZGNX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Raymond James & Associates's ZGNX Position: Q2 2020 in Review

Raymond James & Associates sold out of Zogenix, Inc. (ZGNX) in Q2 2020, closing a stake of 12,259 shares — an estimated $303K sold.

Raymond James & Associates first reported a position in ZGNX in Q4 2017 and held it in 10 quarters. The position peaked at $719K in Q3 2018. 170 funds tracked by Wall St. Rank hold ZGNX as of Q2 2020.

  • Raymond James & Associates reported no remaining Zogenix, Inc. position as of Q2 2020 after selling out during the quarter.
  • Raymond James & Associates sold 12,259 Zogenix, Inc. shares in Q2 2020, an estimated $303K.
  • Raymond James & Associates first reported a position in Zogenix, Inc. in Q4 2017 and held it in 10 quarters.
  • Raymond James & Associates's Zogenix, Inc. position peaked at $719K in Q3 2018.
  • 170 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q2 2020.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.